{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:57:24Z","timestamp":1790085444833,"version":"4.0.1"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2011,7,1]],"date-time":"2011-07-01T00:00:00Z","timestamp":1309478400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["international-journal-of-gynecological-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Gynecological Cancer"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1097\/igc.0b013e318216cb91","type":"journal-article","created":{"date-parts":[[2011,5,25]],"date-time":"2011-05-25T04:01:26Z","timestamp":1306296086000},"page":"822-830","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based Chemotherapy"],"prefix":"10.1016","volume":"21","author":[{"given":"Bahriye","family":"Aktas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Kasimir-Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Heubner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rainer","family":"Kimmig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Wimberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1097\/IGC.0b013e318216cb91_bb0005","article-title":"consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004)","author":"du Bois","year":"2004","journal-title":"Ann Oncol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0010","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"du Bois","year":"2009","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1053\/j.seminoncol.2008.12.003","article-title":"Management of recurrent ovarian carcinoma: current status and future directions","volume":"36","author":"Martin","year":"2009","journal-title":"Semin Oncol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0020","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1111\/IGC.0b013e3181a23c4c","article-title":"Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies","volume":"19","author":"Banys","year":"2009","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0025","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1111\/j.1525-1438.2007.00920.x","article-title":"Prognostic impact of KI67, p53, human epithelial growth factor receptor 2, topoisomerase II alpha, epidermal growth factor receptor, and nm23 expression of ovarian carcinomas and disseminated tumor cells in the bone marrow","volume":"17","author":"Schindlbeck","year":"2007","journal-title":"Int J Gynecol Cancer."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0030","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2007.07.073","article-title":"Influence of platinum-based chemotherapy on disseminated tumor cells in blood and bone marrow of patients with ovarian cancer","volume":"107","author":"Wimberger","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0035","first-page":"1787","article-title":"Influence of catumaxomab on tumor cells in bone marrow and blood in ovarian cancer","volume":"29","author":"Wimberger","year":"2009","journal-title":"Anticancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0040","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/BF03256327","article-title":"Circulating tumor cells as marker for risk assessment and treatment monitoring","volume":"13","author":"Kasimir-Bauer","year":"2009","journal-title":"Mol Diagn Ther."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0045","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.ymeth.2010.01.027","article-title":"Circulating tumour cells in clinical practice: methods of detection and possible characterization","volume":"50","author":"Alunni-Fabbroni","year":"2010","journal-title":"Methods."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0050","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1158\/1078-0432.CCR-08-0030","article-title":"Circulating tumor cell detection predicts early metastatic relapse after neoadjuvant chemotherapy in large operable and locally advanced breast cancer in a phase II randomized trial","volume":"14","author":"Pierga","year":"2008","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0055","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1158\/1078-0432.CCR-07-4758","article-title":"Prognostic value of the molecular detection of circulating tumor cells using a multimarker reverse transcription-PCR assay for cytokeratin 19, mammaglobin A, and HER2 in early breast cancer","volume":"14","author":"Ignatiadis","year":"2008","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0060","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1200\/JCO.2008.18.0497","article-title":"Cytokeratin-19 mRNA-positive circulating tumor cells after adjuvant chemotherapy in patients with early breast cancer","volume":"27","author":"Xenidis","year":"2009","journal-title":"J Clin Oncol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0065","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1186\/bcr2349","article-title":"Detection and characterization of circulating tumor cells in blood of primary breast cancer patients by RT-PCR and comparison to status of bone marrow disseminated cells","volume":"11","author":"Fehm","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0070","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s10549-008-0143-x","article-title":"Molecular profiling and predictive value of circulating tumor cells in patients with metastatic breast cancer: an option for monitoring response to breast cancer related therapies","volume":"115","author":"Tewes","year":"2009","journal-title":"Breast Cancer Res Treat."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0075","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr2333","article-title":"Stem cell and epithelial-mesenchymal transition markers are frequently expressed in metastatic breast cancer patients with circulating tumor cells","volume":"11","author":"Aktas","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0080","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.canlet.2009.06.027","article-title":"Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer","volume":"288","author":"Theodoropoulos","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0085","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1034\/j.1600-0412.2002.810614.x","article-title":"Ovarian tumor cell detection in peripheral blood progenitor cells harvests by RT-PCR","volume":"81","author":"Kurata","year":"2002","journal-title":"Acta Obstet Gynecol Scand."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0090","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1002\/cncr.10250","article-title":"Circulating tumor cells in the peripheral blood and bone marrow of patients with ovarian carcinoma do not predict prognosis","volume":"94","author":"Marth","year":"2002","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0095","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0361-090X(02)00034-X","article-title":"Detection of telomerase-positive circulating epithelial cells in ovarian cancer patients","volume":"26","author":"Sapi","year":"2002","journal-title":"Cancer Detect Prev."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0100","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ygyno.2003.08.004","article-title":"Preoperative detection of peripherally circulating cancer cells and its prognostic significance in ovarian cancer","volume":"91","author":"Judson","year":"2003","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0105","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000092325","article-title":"Kallikreins as markers of disseminated tumour cells in ovarian cancer: a pilot study","volume":"27","author":"Oikonomopoulou","year":"2006","journal-title":"Tumour Biol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0110","first-page":"1968","article-title":"Quantitation of circulating tumor cells in blood samples from ovarian and prostate cancer patients using tumor-specific fluorescent ligands. IntJ","volume":"123","author":"He","year":"2008","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0115","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ygyno.2008.09.021","article-title":"Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer","volume":"112","author":"Fan","year":"2009","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0120","first-page":"465","article-title":"Detection of tumour cells in the peripheral blood of patients with breast cancer. Development of a new sensitive and specific immunomolecular assay","volume":"23","author":"Demel","year":"2004","journal-title":"J Exp Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0125","first-page":"1803","article-title":"Combination of immunomagnetic enrichment with multiplex RT-PCR analysis for the detection of disseminated tumor cells","volume":"25","author":"Zieglschmid","year":"2005","journal-title":"Anticancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0130","unstructured":"Lee KR, Jetal TFP. Surface Epithelial-Stromal Tumours. World Health Organization Classification of Tumours. Tumours of the Breast and Female Genital Organs. Lyon, France: IARC Press; 2003:117\u2013145."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0135","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1097\/00004347-200001000-00003","article-title":"Histopathologic grading of ovarian carcinoma: a review and proposal","volume":"19","author":"Silverberg","year":"2000","journal-title":"Int J Gynecol Pathol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ijgo.2008.12.015","article-title":"Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia","volume":"105","author":"FIGO","year":"2009","journal-title":"Int J Gynaecol Obstet."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0145","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1002\/cncr.22076","article-title":"A concept for the standardized detection of disseminated tumor cells in bone marrow of patients with primary breast cancer and its clinical implementation","volume":"197","author":"Fehm","year":"2006","journal-title":"Cancer."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0150","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1080\/0032472031000141283","article-title":"Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. Establishment of objective criteria for the evaluation of immunostained cells: The European ISHAGE Working Group for Standardization of Tumor Cell Detection","volume":"5","author":"Borgen","year":"1999","journal-title":"Cytotherapy."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0155","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1385\/MB:34:1:15","article-title":"Quantitative real-time RT-PCR of disseminated tumor cells in combination with immunomagnetic cell enrichment","volume":"34","author":"Lankiewicz","year":"2006","journal-title":"Mol Biotechnol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0160","first-page":"1337","article-title":"The clinical significance of circulating tumour cells in breast cancer and colorectal cancer patients","volume":"27","author":"Hauch","year":"2007","journal-title":"Anticancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0165","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1186\/bcr2333","article-title":"Stem cell and epithelial-mesenchymal transition markers are frequently overexpressed in circulating tumor cells of metastatic breast cancer patients","volume":"11","author":"Aktas","year":"2009","journal-title":"Breast Cancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0170","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.ygyno.2007.02.004","article-title":"Expression of MUC1 in primary and metastatic human epithelial ovarian cancer an its therapeutic significance","volume":"105","author":"Wang","year":"2007","journal-title":"Gynecol Oncol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0175","first-page":"809","article-title":"Serological and immunohistochemical HER-2\/neu statuses do not correlate and lack prognostic value for ovarian cancer patients","volume":"19","author":"Hoopmann","year":"2010","journal-title":"EUR J Cancer Care (Engl)."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0180","first-page":"449","article-title":"Tumor cell dissemination in colon cancer does not predict extrahepatic recurrence in patients undergoing surgery for hepatic metastases","volume":"15","author":"Schoppmeyer","year":"2006","journal-title":"Oncol Rep."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0185","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s12609-009-0028-y","article-title":"Minimal residual cancer and its clinical relevance","volume":"1","author":"Rack","year":"2009","journal-title":"Curr Breast Cancer Rep."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0190","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0002-9440(10)61667-7","article-title":"Circulating breast cancer cells are frequently apoptotic","volume":"159","author":"Mehes","year":"2001","journal-title":"Am J Pathol."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0195","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1016\/S0140-6736(03)13718-X","article-title":"ICON and AGO collaborators. Paclitaxel plus platinum-based chemotherapy versus conventional platinum-based chemotherapy in woman with relapsed ovarian cancer: the ICON4\/AGO-OVAR-2.2 trial","volume":"361","author":"Parmar","year":"2003","journal-title":"Lancet."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0200","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s001099900038","article-title":"The biology of the 17-1A antigen (Ep-CAM)","volume":"77","author":"Balzar","year":"1999","journal-title":"J Mol Med."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0205","doi-asserted-by":"crossref","first-page":"3899","DOI":"10.1158\/1078-0432.CCR-06-2769","article-title":"Effective relief of malignant ascites in patients with advanced ovarian cancer by a trifunctional anti-EpCAM x anti-CD3 antibody: a phase I\/II study","volume":"13","author":"Burges","year":"2007","journal-title":"Clin Cancer Res."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0210","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.canlet.2007.06.016","article-title":"High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC)","volume":"25","author":"Moreno","year":"2007","journal-title":"Cancer Lett."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0215","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1357-4310(98)01322-7","article-title":"The biological role of mucins in cellular interactions and immune regulation: prospects for cancer immunotherapy","volume":"4","author":"Agrawal","year":"1998","journal-title":"Mol Med Today."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0220","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1369\/jhc.7A7213.2007","article-title":"Combined staining of TAG-72, MUC1, and CA125 improves labeling sensitivity in ovarian cancer: antigens for multi-targeted antibody-guiede therapy","volume":"55","author":"Chauhan","year":"2007","journal-title":"J Histochem Cytochem."},{"key":"10.1097\/IGC.0b013e318216cb91_bb0225","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1093\/annonc\/mdl357","article-title":"The anti-idiotypic antibody abagovomab in patients with recurrent ovarian cancer. A phase I trial of the AGO-OVAR","volume":"17","author":"Pfisterer","year":"2006","journal-title":"Ann Oncol."}],"container-title":["International Journal of Gynecological Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045353?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1048891X24045353?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.lww.com\/ijgc\/Fulltext\/10.1097\/IGC.0b013e318216cb91","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:35:36Z","timestamp":1753101336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1048891X24045353"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["S1048891X24045353"],"URL":"https:\/\/doi.org\/10.1097\/igc.0b013e318216cb91","relation":{},"ISSN":["1048-891X"],"issn-type":[{"value":"1048-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular Profiling and Prognostic Relevance of Circulating Tumor Cells in the Blood of Ovarian Cancer Patients at Primary Diagnosis and After Platinum-Based Chemotherapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Gynecological Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1097\/IGC.0b013e318216cb91","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright Copyright \u00a9 2011 by IGCS and ESGO.","name":"copyright","label":"Copyright"}]}}